119 related articles for article (PubMed ID: 9109050)
21. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
McNamara DP; Whitney KM; Goss SL
Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
[TBL] [Abstract][Full Text] [Related]
22. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.
Hörter D; Dressman JB
Adv Drug Deliv Rev; 2001 Mar; 46(1-3):75-87. PubMed ID: 11259834
[TBL] [Abstract][Full Text] [Related]
23. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
24. Dissolution of weak acids under laminar flow and rotating disk hydrodynamic conditions: application of a comprehensive convection-diffusion-migration-reaction transport model.
Neervannan S; Southard MZ; Stella VJ
J Pharm Sci; 2012 Sep; 101(9):3180-9. PubMed ID: 22623113
[TBL] [Abstract][Full Text] [Related]
25. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
26. Reaction plane approach for estimating the effects of buffers on the dissolution rate of acidic drugs.
McNamara DP; Amidon GL
J Pharm Sci; 1988 Jun; 77(6):511-7. PubMed ID: 3171931
[TBL] [Abstract][Full Text] [Related]
27. Development of a reaction-limited model of dissolution: application to official dissolution tests experiments.
Dokoumetzidis A; Papadopoulou V; Valsami G; Macheras P
Int J Pharm; 2008 May; 355(1-2):114-25. PubMed ID: 18206324
[TBL] [Abstract][Full Text] [Related]
28. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
29. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
30. pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.
Hamed R; Awadallah A; Sunoqrot S; Tarawneh O; Nazzal S; AlBaraghthi T; Al Sayyad J; Abbas A
AAPS PharmSciTech; 2016 Apr; 17(2):418-26. PubMed ID: 26202065
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
Helmy SA; El Bedaiwy HM
Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
[TBL] [Abstract][Full Text] [Related]
32. Determining the suitability of mass spectrometry for understanding the dissolution processes involved with pharmaceutical tablets.
Lewis C; Ray A; Bristow T; Wren S
Rapid Commun Mass Spectrom; 2015 Jun; 29(12):1107-14. PubMed ID: 25981541
[TBL] [Abstract][Full Text] [Related]
33. Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus.
Wu Y; Ghaly ES
P R Health Sci J; 2006 Mar; 25(1):75-83. PubMed ID: 16883682
[TBL] [Abstract][Full Text] [Related]
34. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
van der Weerd J; Kazarian SG
J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
[TBL] [Abstract][Full Text] [Related]
35. Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation.
Rautio J; Nevalainen T; Taipale H; Vepsäläinen J; Gynther J; Laine K; Järvinen T
Eur J Pharm Sci; 2000 Aug; 11(2):157-63. PubMed ID: 10915963
[TBL] [Abstract][Full Text] [Related]
36. Design and characterization of a new miniaturized rotating disk equipment for in vitro dissolution rate studies.
Persson AM; Baumann K; Sundelöf LO; Lindberg W; Sokolowski A; Pettersson C
J Pharm Sci; 2008 Aug; 97(8):3344-55. PubMed ID: 18000821
[TBL] [Abstract][Full Text] [Related]
37. Dissolution Methods to Increasing Discriminatory Power of In Vitro Dissolution Testing for Ibuprofen Free Acid and Its Salts.
Cristofoletti R; Dressman JB
J Pharm Sci; 2017 Jan; 106(1):92-99. PubMed ID: 27397434
[TBL] [Abstract][Full Text] [Related]
38. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.
Jinno J; Oh Dm; Crison JR; Amidon GL
J Pharm Sci; 2000 Feb; 89(2):268-74. PubMed ID: 10688756
[TBL] [Abstract][Full Text] [Related]
39. Impact of different organic acids on solubility enhancement of cefpodxime proxetil immediate release tablet and its stability studies.
Jabeen S; Hassan F; Yousuf RI; Shoaib MH; Israr F; Hasan SMF; Saeed R; Farooqi S
Pak J Pharm Sci; 2017 May; 30(3):855-866. PubMed ID: 28653931
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases.
Krieg BJ; Taghavi SM; Amidon GL; Amidon GE
J Pharm Sci; 2015 Sep; 104(9):2894-904. PubMed ID: 25980464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
